Cybin Inc./$CYBN
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1Y5YMAX
About Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.
Ticker
$CYBN
Sector
Primary listing
AMEX
Industry
Pharmaceuticals
Headquarters
Toronto, Canada
Employees
50
ISIN
CA23256X4075
Website
Cybin Inc. Metrics
BasicAdvanced
$183M
-
-$4.12
-
-
Price and volume
Market cap
$183M
52-week high
$9.83
52-week low
$4.81
Average daily volume
369K
Financial strength
Current ratio
7.749
Quick ratio
6.579
Profitability
EBITDA (TTM)
-105.105
Management effectiveness
Return on assets (TTM)
-31.92%
Return on equity (TTM)
-42.76%
Valuation
Price to book
0.7
Price to tangible book (TTM)
1.15
Price to free cash flow (TTM)
-2.111
Free cash flow yield (TTM)
-47.38%
Free cash flow per share (TTM)
-376.19%
Growth
Earnings per share change (TTM)
-41.10%
3-year earnings per share growth (CAGR)
-28.58%
Cybin Inc. News
AllArticlesVideos

REPEAT/Cybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures
Business Wire·3 days ago

Cybin Reports Fiscal Year 2025 Financial Results and Recent Business Highlights
Business Wire·4 days ago

Cybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures
Business Wire·4 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Cybin Inc. stock?
Cybin Inc. (CYBN) has a market cap of $183M as of July 05, 2025.
What is the P/E ratio for Cybin Inc. stock?
The price to earnings (P/E) ratio for Cybin Inc. (CYBN) stock is 0 as of July 05, 2025.
Does Cybin Inc. stock pay dividends?
No, Cybin Inc. (CYBN) stock does not pay dividends to its shareholders as of July 05, 2025.
When is the next Cybin Inc. dividend payment date?
Cybin Inc. (CYBN) stock does not pay dividends to its shareholders.
What is the beta indicator for Cybin Inc.?
Cybin Inc. (CYBN) does not currently have a Beta indicator.